⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CLRB News
Cellectar Biosciences INC NEW
Cellectar Biosciences Reports Positive 12-Month Follow-Up Data from Phase 2b CLOVER WaM Study Demonstrating Durable Responses and Efficacy of Iopofosine I 131 in r/r Waldenström Macroglobulinemia
globenewswire.com
CLRB
Cellectar Biosciences Announces Oversubscribed Financing Up to $140 Million
globenewswire.com
CLRB
Form 8-K
sec.gov
BRNS
MXCT
SLDB
CLRB
Follicular Lymphoma Clinical Trial Space Intensifies with 45+ Companies in Active Development | DelveInsight
globenewswire.com
AZN
CRSP
NKTR
INCY
IPHA
ABBV
BIIB
ALKS
IMVT
CLRB
IMPP
REGN
THO
AUTL
KYMR
CBIO
GILD
Cellectar Biosciences Announces Subset of CLOVER WaM Clinical Trial Data Accepted for Presentation at the American Society of Clinical Oncology Conference 2026
globenewswire.com
CLRBW
CLRB
CLRBZ
Cellectar Enrolls First Patient in CLR 125 Auger-Emitting Radioconjugate Phase 1b Clinical Trial Targeting Refractory Triple Negative Breast Cancer (TNBC)
globenewswire.com
CLRBW
CLRB
CLRBZ
IoT Middleware Market worth $58.63 billion by 2032 - Exclusive Report by MarketsandMarkets™
prnewswire.com
MSFT
IBM
PTC
CSCO
AMZN
GOOGL
ORCL
HPE
GE
RBLX
CLRB
LITM
Verint Names Teresa Anania Chief Customer Officer
businesswire.com
VRNT
CLRB
Form 8-K
sec.gov
CLRB
Cellectar Biosciences Reports Financial Results for Year Ended 2025 and Provides Corporate Updates
globenewswire.com
CLRBW
CLRB
CLRBZ